Phase 2 Airway Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
COPDCOPD ExacerbationImmune System Disorder+2 more
Asger Sverrild80 enrolled2 locationsNCT05507242
Recruiting
Phase 2
Biological Effects of Quercetin in COPD Phase II
Chronic Obstructive Pulmonary DiseaseEmphysemaChronic Bronchitis With Airway Obstruction
Temple University30 enrolled1 locationNCT06003270
Completed
Phase 2
Remi-Fent1 Study: A Comparison of Remifentanil and Fentanyl in Mechanically Ventilated Patients
Control refractory seizuresRespiratory failure
- issues with oxygenation or ventilationPrevent secondary brain injury+3 more
Arvind Rajamani100 enrolled1 locationACTRN12620000719932
Completed
Phase 2
Effects of noradrenergic and antimuscarinic agents on upper airway muscle activity during sleep
Upper airway muscle activity asleep
Neuroscience Research Australia (NeuRA)10 enrolled1 locationACTRN12616000469415
Completed
Phase 2
An oral killed non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with mild to moderate airways disease: Safety and efficacy study
Acute bronchitis in mild to moderate airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000076572
Completed
Phase 2
An oral killed Non-typeable Haemophilus influenzae vaccine for preventing episodes of acute bronchitis in patients with moderate to severe airways disease: Safety and efficacy study
Acute bronchitis in moderate to severe airway disease
Hunter Immunology Ltd124 enrolled1 locationACTRN12606000074594